Chronic toxicology of cannabis

References

• United Nations Office of Drugs and Crime World Drug Report 2008. Vienna:UN ODC, 2008.
   Google Scholar
• Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370:319–328.
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Hjorthoj C. Cannabis use and risk of psychosis in later life. Lancet 2007; 370:293–294.
   PubMed Web of Science ®Google Scholar
• British Lung Foundation. Cannabis: a smoking gun. London; 2005. http://www.lunguk.org/Resources/British%20Lung%Foundation/Migrated%20Resources/Documents/A/A_Smoking_Gun.pdf. Accessed 20 June 2009.
   Google Scholar
• Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31:608–612.
   PubMed Web of Science ®Google Scholar
• Konings M, Henquet C, Maharajh HD, Hutchinson G, Van Os J. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatr Scand 2008; 118:209–213.
   PubMed Web of Science ®Google Scholar
• Cohen M, Solowij N, Carr V. Cannabis, cannabinoids and schizophrenia: integration of the evidence. Aust NZ J Psychiatry 2008; 42:357–368.
   PubMed Web of Science ®Google Scholar
• Coulston CM, Perdices M, Tennant CC. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Aust NZ J Psychiatry 2007; 41:869–884.
   PubMed Web of Science ®Google Scholar
• Coulston CM, Perdices M, Tennant CC. The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use. Schizophr Res 2007; 96:169–184.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Tennant C, Gilmour S. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med 2007; 37:927–934.
   PubMed Web of Science ®Google Scholar
• Esterberg ML, Goulding SM, McClure-Tone EB, Compton MT. Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample. Addict Behav 2008; 34:374–379.
   PubMed Web of Science ®Google Scholar
• Freedman R. Cannabis, inhibitory neurons, and the progressive course of schizophrenia. Am J Psychiatry 2008; 165:416–419.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 2008; 165:479–489.
   PubMed Web of Science ®Google Scholar
• Henquet C, Van Os J. The coherence of the evidence linking cannabis with psychosis. Psychol Med 2008; 38:461–462 author reply 2–4.
   PubMedGoogle Scholar
• Hides L, Dawe S, Kavanagh DJ, Young RM. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. Br J Psychiatry 2006; 189:137–143.
   PubMed Web of Science ®Google Scholar
• Linszen D, van Amelsvoort T. Cannabis and psychosis: an update on course and biological plausible mechanisms. Curr Opin Psychiatry 2007; 20:116–120.
   PubMed Web of Science ®Google Scholar
• Luzi S, Morrison PD, Powell J, di Forti M, Murray RM. What is the mechanism whereby cannabis use increases risk of psychosis?. Neurotox Res 2008; 14:105–112.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997; 92:279–296.
   PubMed Web of Science ®Google Scholar
• Jarvis K, DelBello MP, Mills N, Elman I, Strakowski SM, Adler CM. Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. J Child Adolesc Psychopharmacol 2008; 18:557–563.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Herrell R, Swendsen J, Rossler W, Ajdacic-Gross V, Angst J. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study. Arch Gen Psychiatry 2008; 65:47–52.
   PubMed Web of Science ®Google Scholar
• van Rossum I, Boomsma M, Tenback D, Reed C, van Os J. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. T J Nerv Ment Dis 2009; 197:35–40.
   PubMed Web of Science ®Google Scholar
• Wichers M, Schrijvers D, Geschwind N, Jacobs N, Myin-Germeys I, Thiery E, Derom C, Sabbe B, Peeters F, Delespaul P, Van Os J. Mechanisms of gene-environment interactions in depression: evidence that genes potentiate multiple sources of adversity. Psychol Med; 2008:1–10.
   Google Scholar
• Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158:2033–2037.
   PubMed Web of Science ®Google Scholar
• Lee KS, Clough AR, Jaragba MJ, Conigrave KM, Patton GC. Heavy cannabis use and depressive symptoms in three Aboriginal communities in Arnhem Land, Northern Territory. Med J Aust 2008; 188:605–608.
   PubMed Web of Science ®Google Scholar
• Konings M, Maharajh HD. Cannabis use and mood disorders: patterns of clinical presentations among adolescents in a developing country. Int J Adolesc Med Health 2006; 18:221–233.
   PubMedGoogle Scholar
• Moore TM, Stuart GL, Meehan JC, Rhatigan DL, Hellmuth JC, Keen SM. Drug abuse and aggression between intimate partners: a meta-analytic review. Clin Psychol Rev 2008; 28:247–274.
   PubMed Web of Science ®Google Scholar
• Eksborg S, Rajs J. Causes and manners of death among users of heroin, methadone, amphetamine, and cannabis in relation to postmortem chemical tests for illegal drugs. Subst Use Misuse 2008; 43:1326–1339.
   PubMed Web of Science ®Google Scholar
• Nahas GG. Effects of hashish consumption in Egypt. N Engl J Med 1972; 287:310.
   PubMed Web of Science ®Google Scholar
• Wells JE, Degenhardt L, Bohnert KM, Anthony JC, Scott KM. Geographical clustering of cannabis use: results from the New Zealand Mental Health Survey 2003–2004. Drug Alcohol Depend 2009; 99:309–316.
   PubMed Web of Science ®Google Scholar
• Voirin N, Berthiller J, Benhaim-Luzon V, Boniol M, Straif K, Ayoub WB, Ayed FB, Sasco AJ. Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol 2006; 1:577–579.
   PubMed Web of Science ®Google Scholar
• Berthiller J, Straif K, Boniol M, Voirin N, Benhaïm-Luzon V, Ayoub WB, Dari I, Laouamri S, Hamdi-Cherif M, Bartal M, Ayed FB, Sasco AJ. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 2008; 3:1398–1403.
   PubMed Web of Science ®Google Scholar
• Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R. Cannabis and Respiratory Disease Research Group. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008; 31:280–286.
   PubMed Web of Science ®Google Scholar
• Lee KS, Conigrave KM, Patton GC, Clough AR. Cannabis use in remote Indigenous communities in Australia: endemic yet neglected. Med J Aust 2009; 190:228–229.
   PubMed Web of Science ®Google Scholar
• Lee KS, Clough AR, Conigrave KM. High levels of cannabis use persist in Aboriginal communities in Arnhem Land, Northern Territory. Med J Aust 2007; 187:594–595.
   PubMed Web of Science ®Google Scholar
• Taylor DR, Hall W. Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand. Int Med J 2003; 33:310–313.
   Google Scholar
• British Lung Foundation Cannabis: A Smoking Gun. London:British Lung Foundation, 2005.
   Google Scholar
• Tashkin DP. Smoked marijuana as a cause of lung injury. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace/Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo 2005; 63:93–100.
   Google Scholar
• Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, Robinson G, Beasley R. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007; 62:1058–1063.
   PubMed Web of Science ®Google Scholar
• Lange P. Cannabis and the lung. Thorax 2007; 62:1036–1037.
   PubMed Web of Science ®Google Scholar
• Research confirms cannabis poses a serious health risk to the lungs. British Lung Foundation, 2007. http://www.lunguk.org/media-and-campaigning/media-centre/archive-press-releases-and-statements/july2007/Researchconfirmscannabisposesaserioushealthrisktothelungs.htm. Accessed 20 June 2009.
   Google Scholar
• Johnson MK, Smith RP, Morrison D, Laszlo G, White RJ. Large lung bullae in marijuana smokers. Thorax 2000; 55:340–342.
   PubMed Web of Science ®Google Scholar
• Thompson CS, White RJ. Lung bullae and marijuana. Thorax 2002; 57:563.
   PubMed Web of Science ®Google Scholar
• Reece AS. Cannabis as a cause of giant cystic lung disease. Q J Medicine 2008; 101:503.
   Google Scholar
• Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP, Yu GP, Marshall JR, Hsu TC, Schantz SP. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999; 8:1071–1078.
   PubMed Web of Science ®Google Scholar
• Hashibe M, Straif K, Tashkin DP, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk. Alcohol (Fayetteville, NY) 2005; 35:265–275.
   PubMed Web of Science ®Google Scholar
• Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin DP, Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Am J Respir Cell Mol Biol 2001; 24:339–344.
   PubMed Web of Science ®Google Scholar
• Sarafian TA, Magallanes JA, Shau H, Tashkin D, Roth MD. Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol 1999; 20:1286–1293.
   PubMed Web of Science ®Google Scholar
• Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42:58S–63S.
   PubMed Web of Science ®Google Scholar
• Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G. Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 1996; 28:682–686.
   PubMed Web of Science ®Google Scholar
• Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002; 42:64S–70S.
   PubMed Web of Science ®Google Scholar
• Strougo A, Zuurman L, Roy C, Pinquier JL, van Gerven JMA, Cohen AF, Schoemaker RC. Modelling of the concentration – effect relationship of THC on central nervous system parameters and heart rate – insight into its mechanisms of action and a tool for clinical research and development of cannabinoids. J Psychopharmacol (Oxford) 2008; 22:717–726.
   PubMed Web of Science ®Google Scholar
• Mukamal KJ, Maclure M, Muller JE, Mittleman MA. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J 2008; 155:465–470.
   PubMed Web of Science ®Google Scholar
• Lambrecht GL, Malbrain ML, Coremans P, Verbist L, Verhaegen H. Acute renal infarction and heavy marijuana smoking. Nephron 1995; 70:494–496.
   PubMedGoogle Scholar
• Reece AS. Severe multisystem dysfunction in a case of high level exposure to smoked cannabis. BMJ Case Reports; 2009.
   Google Scholar
• Zachariah SB. Stroke after heavy marijuana smoking. Stroke 1991; 22:406–409.
   PubMed Web of Science ®Google Scholar
• Mateo I, Pinedo A, Gomez-Beldarrain M, Basterretxea JM, Garcia-Monco JC. Recurrent stroke associated with cannabis use. J Neurol Neurosurg Psychiatry 2005; 76:435–437.
   PubMed Web of Science ®Google Scholar
• Russmann S, Winkler A, Lovblad KO, Stanga Z, Bassetti C. Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation. Eur Neurol 2002; 48:178–180.
   PubMed Web of Science ®Google Scholar
• Moussouttas M. Cannabis use and cerebrovascular disease. Neurologist 2004; 10:47–53.
   PubMed Web of Science ®Google Scholar
• Termote B, Verswijvel G, Gelin G, Palmers Y. Cannabis-induced brain ischemia. JBR-BTR 2007; 90:218–219.
   PubMed Web of Science ®Google Scholar
• Renard D, Gaillard N. Brain haemorrhage and cerebral vasospasm associated with chronic use of cannabis and buprenorphine. Cerebrovasc Dis 2008; 25:282–283.
   PubMed Web of Science ®Google Scholar
• Citron BP. Angiitis in drug abusers. N Engl J Med 1971; 284:111.
   PubMed Web of Science ®Google Scholar
• Charles R, Holt S, Kirkham N. Myocardial infarction and marijuana. Clin Toxicol 1979; 14:433–438.
   PubMed Web of Science ®Google Scholar
• Kotsalou I, Georgoulias P, Karydas I, Fourlis S, Sioka C, Zoumboulidis A, Demakopoulos N. A rare case of myocardial infarction and ischemia in a cannabis-addicted patient. Clin Nucl Med 2007; 32:130–131.
   PubMed Web of Science ®Google Scholar
• Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001; 103:2805–2809.
   PubMed Web of Science ®Google Scholar
• Montisci M, Thiene G, Ferrara SD, Basso C. Cannabis and cocaine: a lethal cocktail triggering coronary sudden death. Cardiovasc Pathol 2008; 17:344–3446.
   PubMed Web of Science ®Google Scholar
• Noel B, Ruf I, Panizzon RG. Cannabis arteritis. J Am Acad Dermatol 2008; 58:S65–S67.
   PubMed Web of Science ®Google Scholar
• Peyrot I, Garsaud AM, Saint-Cyr I, Quitman O, Sanchez B, Quist D. Cannabis arteritis: a new case report and a review of literature. J Eur Acad Dermatol Venereol 2007; 21:388–391.
   PubMed Web of Science ®Google Scholar
• Birnbaum BF, Pinzone JJ. Sickle cell trait and priapism: a case report and review of the literature. Cases J 2008; 1:429.
   PubMedGoogle Scholar
• Cappelli F, Lazzeri C, Gensini GF, Valente S. Cannabis: a trigger for acute myocardial infarction? A case report. J Cardiovasc Med 2008; 9:725–728.
   Google Scholar
• Ting JY. Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult. Clin Toxicol (Phila) 2007; 45:432–434.
   PubMed Web of Science ®Google Scholar
• Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130:3091–3101.
   PubMed Web of Science ®Google Scholar
• Mathew RJ, Wilson WH, Humphreys DF, Lowe JV, Wiethe KE. Middle cerebral artery velocity during upright posture after marijuana smoking. Acta Psychiatr Scand 1992; 86:173–178.
   PubMed Web of Science ®Google Scholar
• Mathew RJ, Wilson WH, Humphreys DF, Lowe JV, Wiethe KE. Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab 1992; 12:750–758.
   PubMed Web of Science ®Google Scholar
• Disdier P, Granel B, Serratrice J, Constans J, Michon-Pasturel U, Hachulla E, Conri C, Devulder B, Swiader L, Piquet P, Branchereau A, Jouglard J, Moulin G, Weiller PJ. Cannabis arteritis revisited – ten new case reports. Angiology 2001; 52:1–5.
   PubMed Web of Science ®Google Scholar
• Ducasse E, Chevalier J, Dasnoy D, Speziale F, Fiorani P, Puppinck P. Popliteal artery entrapment associated with cannabis arteritis. Eur J Vasc Endovasc Surg 2004; 27:327–332.
   PubMed Web of Science ®Google Scholar
• Kanakis CJr, Pouget JM, Rosen KM. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Circulation 1976; 53:703–707.
   PubMed Web of Science ®Google Scholar
• Olinger GN, Mulder DG, Maloney JVJr, Buckberg GD. Phasic coronary flow: intraoperative evaluation of flow distribution, myocardial function, and reactive hyperemic response. Ann Thorac Surg 1976; 21:397–404.
   PubMed Web of Science ®Google Scholar
• Olinger GN, Po J, Maloney JVJr, Mulder DG, Buckberg GD. Myocardial revascularization in high-risk coronary patients. West J Med 1976; 124:265–271.
   PubMedGoogle Scholar
• Kogan NM, Blazquez C, Alvarez L, Gallily R, Schlesinger M, Guzmán M, Mechoulam R. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells. Mol Pharmacol 2006; 70:51–59.
   PubMed Web of Science ®Google Scholar
• Korantzopoulos P, Liu T, Papaioannides D, Li G, Goudevenos JA. Atrial fibrillation and marijuana smoking. Int J Clin Pract 2008; 62:308–313.
   PubMed Web of Science ®Google Scholar
• Charbonney E, Sztajzel JM, Poletti PA, Rutschmann O. Paroxysmal atrial fibrillation after recreational marijuana smoking: another ‘holiday heart’?. Swiss Med Wkly 2005; 135:412–414.
   PubMed Web of Science ®Google Scholar
• Kosior DA, Filipiak KJ, Stolarz P, Opolski G. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication – a case report of possible association. Med Sci Monit 2000; 6:386–389.
   PubMedGoogle Scholar
• Lehavi A, Shay M, Gilony C, Even L. Marijuana smoking and paroxysmal atrial fibrillation. Harefuah 2005; 1442–372.
   Google Scholar
• Baranchuk A, Johri AM, Simpson CS, Methot M, Redfearn DP. Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report. Cases J 2008; 1:373.
   PubMedGoogle Scholar
• Cote M, Matias I, Lemieux I, Petrosino S, Alméras N, Després J-P, Di Marzo V. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (2005) 2007; 31:692–699.
   PubMed Web of Science ®Google Scholar
• Idris AI, van't Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 2005; 117774–779.
   PubMed Web of Science ®Google Scholar
• George KL, Saltman LH, Stein GS, Lian JB, Zurier RB. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. J Cell Physiol 2008; 2143714–720.
   PubMed Web of Science ®Google Scholar
• Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A. Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol 2008; 20Suppl. 169–74.
   PubMedGoogle Scholar
• Bab I, Zimmer A. Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol 2008; 153:182–188.
   PubMed Web of Science ®Google Scholar
• Bab IA. Regulation of skeletal remodeling by the endocannabinoid system. Ann N Y Acad Sci 2007; 1116:414–422.
   PubMed Web of Science ®Google Scholar
• Buckley NE. The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol 2008; 153:309–318.
   PubMed Web of Science ®Google Scholar
• George KL, Saltman LH, Stein GS, Lian JB, Zurier RB. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. J Cell Physiol 2008; 214:714–720.
   PubMed Web of Science ®Google Scholar
• Johnson DR, Stebulis JA, Rossetti RG, Burstein SH, Zurier RB. Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid. J Cell Biochem 2007; 100:184–190.
   PubMed Web of Science ®Google Scholar
• Lunn CA, Reich EP, Fine JS, Lavey B, Kozlowski JA, Hipkin RW, Lundell DJ, Bober L. Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists. Br J Pharmacol 2008; 1532226–239.
   PubMed Web of Science ®Google Scholar
• Napimoga MH, Benatti BB, Lima FO, Alves PM, Campos AC, Pena-Dos-Santos DR, Severino FP, Cunha FQ, Guimaraes FS. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol 2008; 92216–222.
   PubMed Web of Science ®Google Scholar
• Tam J, Trembovler V, Di Marzo V, Petrosino S, Leo G, Alexandrovich A, Regev E, Casap N, Shteyer A, Ledent C, Karsak M, Zimmer A, Mechoulam R, Yirmiya R, Shohami E, Bab I. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J 2008; 22:285–294.
   PubMed Web of Science ®Google Scholar
• Patinkin D, Milman G, Breuer A, Fride E, Mechoulam R. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation. Eur J Pharmacol 2008; 595:1–6.
   Google Scholar
• Rossi F, Siniscalco D, Luongo L, De Petrocellis L, Bellini G, Petrosino S, Torella M, Santoro C, Nobili B, Perrotta S, Di Marzo V, Maione S. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone 2008; 44:476–484.
   PubMed Web of Science ®Google Scholar
• Tam J, Ofek O, Fride E, Ledent C, Gabet Y, Müller R, Zimmer A, Mackie K, Mechoulam R, Shohami E, Bab I. Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol Pharmacol 2006; 70:786–792.
   PubMed Web of Science ®Google Scholar
• Newman MG, Takei HH, Carranza FA Carranza's Clinical Periodontology. London:W.B. Saunders & Co, 2002.
   Google Scholar
• Reece AS. Dentition of addiction in Queensland: poor dental status and major contributing drugs. Aust Dent Jl 2007; 52:144–149.
   PubMed Web of Science ®Google Scholar
• Versteeg PA, Slot DE, van der Velden U, van der Weijden GA. Effect of cannabis usage on the oral environment: a review. Int J Dent Hyg 2008; 6:315–320.
   PubMedGoogle Scholar
• Nogueira-Filho Gda R, Cadide T, Rosa BT. Cannabis sativa smoke inhalation decreases bone filling around titanium implants: a histomorphometric study in rats. Implant Dent 2008; 17:461–470.
   PubMed Web of Science ®Google Scholar
• Hujoel PP. Destructive periodontal disease and tobacco and cannabis smoking. JAMA 2008; 299:574–575.
   PubMed Web of Science ®Google Scholar
• Thomson WM, Poulton R, Broadbent JM, Moffitt TE, Caspi A, Beck JD, Welch D, Hancox RJ. Cannabis smoking and periodontal disease among young adults. JAMA 2008; 2995525–531.
   PubMed Web of Science ®Google Scholar
• Fried PA. Postnatal consequences of maternal marijuana use. NIDA Res Monogr 1985; 59:61–72.
   PubMedGoogle Scholar
• Davitian C, Uzan M, Tigaizin A, Ducarme G, Dauphin H, Poncelet C. Maternal cannabis use and intra-uterine growth restriction. Gynecol Obstet Fertil 2006; 34:632–637.
   PubMedGoogle Scholar
• Forrester MB, Merz RD. Risk of selected birth defects with prenatal illicit drug use, Hawaii, 1986–2002. J Toxicol Environ Health 2007; 70:7–18.
   PubMed Web of Science ®Google Scholar
• van Gelder MM, Reefhuis J, Caton AR, Werler MM, Druschel CM, Roeleveld N. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology 2009; 20:60–66.
   PubMed Web of Science ®Google Scholar
• Weinsheimer RL, Yanchar NL. Impact of maternal substance abuse and smoking on children with gastroschisis. J Pediatr Surg 2008; 43:879–883.
   PubMed Web of Science ®Google Scholar
• Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 2001; 23:1–11.
   PubMed Web of Science ®Google Scholar
• O'Connell CM, Fried PA. Prenatal exposure to cannabis: a preliminary report of postnatal consequences in school-age children. Neurotoxicol Teratol 1991; 13:631–639.
   PubMed Web of Science ®Google Scholar
• Sundram S. Cannabis and neurodevelopment: implications for psychiatric disorders. Hum Psychopharmacol 2006; 21:245–254.
   PubMed Web of Science ®Google Scholar
• Nelson EC, Heath AC, Lynskey MT, Bucholz KK, Madden PA, Statham DJ, Martin NG. Childhood sexual abuse and risks for licit and illicit drug-related outcomes: a twin study. Psychol Med 2006; 36101473–1483.
   PubMed Web of Science ®Google Scholar
• Goldschmidt L, Richardson GA, Willford J, Day NL. Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry 2008; 47:254–263.
   PubMed Web of Science ®Google Scholar
• Fried PA. Prenatal exposure to marihuana and tobacco during infancy, early and middle childhood: effects and an attempt at synthesis. Arch Toxicol Suppl 1995; 17:233–260.
   PubMedGoogle Scholar
• Fried PA. Postnatal consequences of maternal marijuana use. NIDA Res Monogr 1998; 59:61–72.
   Google Scholar
• Day NL, Goldschmidt L, Thomas CA. Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14. Addiction 2006; 101:1313–1322.
   PubMed Web of Science ®Google Scholar
• Hashibe M, Ford DE, Zhang ZF. Marijuana smoking and head and neck cancer. J Clin Pharmacol 2002; 42:103S–107S.
   PubMed Web of Science ®Google Scholar
• Sidney S, Quesenberry CPJr, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control 1997; 8:722–728.
   PubMed Web of Science ®Google Scholar
• Doody DR, Sun X, Trabert BL, Weiss NS, Chen C, Biggs ML, Starr JR, Dey SK, Schwartz SM, Daling JR. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 2009; 115:1215–1223.
   PubMed Web of Science ®Google Scholar
• Efird JT, Friedman GD, Sidney S, Klatsky A, Habel LA, Udaltsova NV, Van den Eeden S, Nelson LM. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J neuro-oncol 2004; 68157–69.
   PubMed Web of Science ®Google Scholar
• Moiche Bokobo P, Atxa de la Presa MA, Cuesta Angulo J. Transitional cell carcinoma in a young heavy marihuana smoker. Arch Esp Urol 2001; 54:165–167.
   PubMedGoogle Scholar
• Chacko JA, Heiner JG, Siu W, Macy M, Terris MK. Association between marijuana use and transitional cell carcinoma. Urology 2006; 67:100–104.
   PubMed Web of Science ®Google Scholar
• Nieder AM, Lipke MC, Madjar S. Transitional cell carcinoma associated with marijuana: case report and review of the literature. Urology 2006; 67:200.
   PubMedGoogle Scholar
• Bluhm EC, Daniels J, Pollock BH, Olshan AF. Maternal use of recreational drugs and neuroblastoma in offspring: a report from the Children's Oncology Group (United States). Cancer Causes Control 2006; 17:663–669.
   PubMed Web of Science ®Google Scholar
• Robinson LL, Buckley JD, Daigle AE, Wells R, Benjamin D, Arthur DC, Hammond GD. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer 1989; 63:1904–1911.
   PubMed Web of Science ®Google Scholar
• Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R. Cannabis and Respiratory Disease Research Group. Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg 2008; 138:374–380.
   PubMedGoogle Scholar
• Hashibe M, Morgenstern H, Cui Y, Tashkin DP, Zhang ZF, Cozen W, Mack TM, Greenland S. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006; 15:1829–1834.
   PubMed Web of Science ®Google Scholar
• Jones JD, Carney ST, Vrana KE, Norford DC, Howlett AC. Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells. Neuropharmacology 2008; 54:23–30.
   PubMed Web of Science ®Google Scholar
• McCollum L, Howlett AC, Mukhopadhyay S. Anandamide-mediated CB1/CB2 cannabinoid receptor – independent nitric oxide production in rabbit aortic endothelial cells. J Pharmacol Exp Ther 2007; 321:930–937.
   PubMed Web of Science ®Google Scholar
• Howlett AC, Mukhopadhyay S, Norford DC. Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies. J Neuroimmune Pharmacol 2006; 1:305–316.
   PubMed Web of Science ®Google Scholar
• Sarafian TA, Habib N, Oldham M, Seeram N, Lee R-P, Lin L, Tashkin DP, Roth MD. Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo. Am J Physiol 2006; 290:L1202–L1209.
   PubMed Web of Science ®Google Scholar
• Sarafian TA, Kouyoumjian S, Khoshaghideh F, Tashkin DP, Roth MD. Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am J Physiol 2003; 284:L298–306.
   PubMed Web of Science ®Google Scholar
• Sarker KP, Obara S, Nakata M, Kitajima I, Maruyama I. Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Lett 2000; 472:39–44.
   PubMed Web of Science ®Google Scholar
• Todd F, McLean S, Krum H, Martin J, Copeland J. Cannabis. In: Hulse GWJCape G eds. Management of Drug and Alcohol Problems. Oxford:Oxford University Press, 2002141–156.
   Google Scholar
• Bentires-Alj M, Kontaridis MI, Neel BG. Stops along the RAS pathway in human genetic disease. Nat Med 2006; 12:283–285.
   PubMed Web of Science ®Google Scholar
• Kogan NM, Schlesinger M, Peters M, Marincheva G, Beeri R, Mechoulam R. A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study. J Pharmacol Exp Ther 2007; 322:646–653.
   PubMed Web of Science ®Google Scholar
• Kogan NM, Schlesinger M, Priel E, Rabinowitz R, Berenshtein E, Chevion M, Mechoulam R. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. Mol Cancer Ther 2007; 6:173–183.
   PubMed Web of Science ®Google Scholar
• Zimmerman AM, Zimmerman S, Raj AY. Effects of Cannabinoids on spermatogenesis in mice. In: Nahas GGSutin KMHarvey DJAgurell S eds. Marihuana and Medicine. Totowa, NJ:Humana Press, 1999347–358.
   Google Scholar
• de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100–2110.
   PubMed Web of Science ®Google Scholar
• Wang F, Podell ER, Zaug AJ, Yang Y, Baciu P, Cech TR, Lei M. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007; 445:506–510.
   PubMed Web of Science ®Google Scholar
• Capper R, Britt-Compton B, Tankimanova M, Rowson J, Letsolo B, Man S, Haughton M, Baird DM. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev 2007; 21:2495–2508.
   PubMed Web of Science ®Google Scholar
• Baird DM. Telomere dynamics in human cells. Biochimie 2008; 90:116–121.
   PubMed Web of Science ®Google Scholar
• Flores I, Canela A, Vera E, Tejera A, Cotsarelis G, Blasco MA. The longest telomeres: a general signature of adult stem cell compartments. Genes Dev; 2008.
   Web of Science ®Google Scholar
• Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses 2006; 66:234–246.
   PubMed Web of Science ®Google Scholar
• Sarafian T, Habib N, Mao JT, Tsu IH, Yamamoto ML, Hsu E, Tashkin DP, Roth MD. Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett 2005; 158:95–107.
   PubMed Web of Science ®Google Scholar
• Li JH, Lin LF. Genetic toxicology of abused drugs: a brief review. Mutagenesis 1998; 13:557–565.
   PubMed Web of Science ®Google Scholar
• Morishima A. Effects of cannabis and natural cannabinoids on chromosomes and ova. NIDA Res Monogr 1984; 44:25–45.
   PubMedGoogle Scholar
• Canela A, Klatt P, Blasco MA. Telomere length analysis. Methods Mol Biol 2007; 371:45–72.
   PubMedGoogle Scholar
• Samper E, Fernandez P, Eguia R, Martín-Rivera L, Bernad A, Blasco MA, Aracil M. Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood 2002; 99:2767–2775.
   PubMed Web of Science ®Google Scholar
• Franco S, Alsheimer M, Herrera E, Benavente R, Blasco MA. Mammalian meiotic telomeres: composition and ultrastructure in telomerase-deficient mice. Eur J Cell Biol 2002; 81:335–340.
   PubMed Web of Science ®Google Scholar
• The adverse health effects of cannabis use: what are they, and what are their implications for policy?. Int J Drug Policy; 2009 Hall Wepub ahead of print April 14, 2009.
   Google Scholar
• Hall W, Lynskey M. The challenges in developing a rational cannabis policy. Curr Opin Psychiatry 2009; 22:258–262.
   PubMed Web of Science ®Google Scholar